Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

IPO/Stock Watch

Market trends, bell-weather stocks, filings and IPOs...

Apollomics, a US-China Biopharma, will Merge with SPAC to List on NASDAQ Exchange

Lepu Medical, a Medical Device Company, Raises $224 Million by Listing on Swiss Exchange

Biocytogen Closes $60 Million Hong Kong IPO for Animal Models and Drug Development

Genuine Biotech Files for Hong Kong IPO to Support Novel Drug Portfolio

InvestisBio Completes $296 Million IPO on the Shanghai STAR Board

ChinaBio Event
Beijing and Digital
November 8-11, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022